Charles River Laboratories International, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Quarterly earnings show how the company performed and help investors track profit trends.
Quarterly earnings reveal company performance and help investors understand business health.
New incentive plan affects how employees and executives are rewarded, impacting future costs.
Board elections show who leads the company and makes major decisions.
Divestiture of 143 million dollar revenue businesses changes company size and focus areas.
Sale of 144 million dollar revenue business generates cash and reshapes company operations.
New CFO with 30 years experience leads financial decisions affecting company performance.
Stocky reads Charles River Laboratories International, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Charles River Laboratories International, Inc.'s most recent tracked filing was a 10-Q on 5 Aug 2026: Charles River reports second quarter 2026 financial results.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.